What is the main cause of fecal incontinence in postmenopausal women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Main Cause of Fecal Incontinence in Postmenopausal Women

The primary cause of fecal incontinence in postmenopausal women is bowel disturbances—particularly diarrhea—rather than obstetric history, with diarrhea carrying an odds ratio of 53 for fecal incontinence. 1

Understanding the Dominant Risk Factors

The evidence clearly establishes that diarrhea is by far the most important independent risk factor for fecal incontinence in older women, followed by rectal urgency and burden of chronic illness 1. This finding challenges the common assumption that obstetric trauma is the primary driver in postmenopausal women.

Primary Risk Factors (in order of importance):

  • Diarrhea (OR = 53; 95% CI = 6.1-471) 1
  • History of rectocele (OR = 4.9; 95% CI = 1.3-19) 1
  • Current smoking (OR = 4.7; 95% CI = 1.4-15) 1
  • Cholecystectomy (OR = 4.2; 95% CI = 1.2-15) 1
  • Stress urinary incontinence (OR = 3.1; 95% CI = 1.4-6.5) 1
  • Higher BMI (per unit increase, OR = 1.1) 1

The Role of Menopause and Hormonal Changes

Menopause itself is an independent risk factor for fecal incontinence (OR = 5.67; 95% CI = 1.35-23.78) 2. The hormonal changes associated with menopause appear to alter neuromuscular continence mechanisms 3.

Menopausal Hormone Therapy Paradox:

Interestingly, menopausal hormone therapy (MHT) actually increases the risk of fecal incontinence rather than protecting against it 3:

  • Current MHT users have a hazard ratio of 1.32 (95% CI = 1.20-1.45) 3
  • Past MHT users have a hazard ratio of 1.26 (95% CI = 1.18-1.34) 3
  • Risk increases with longer duration of use and is higher with combination estrogen-progestin therapy (HR = 1.37) compared to estrogen monotherapy 3

Pelvic Floor Dysfunction as the Underlying Mechanism

Deficient pelvic floor support from direct or denervation injury to pelvic floor musculature is the structural basis for fecal incontinence in this population 1. This results from:

  • Advanced age 1
  • Vaginal multiparity (though less important than bowel disturbances in community surveys) 1
  • Obesity 1
  • Chronic straining and increased intra-abdominal pressure 1

The prevalence of anal incontinence increases with parity, ranging from 8.3% to 11.8% in postmenopausal women 1. Among women who gave birth vaginally, 26% have anal sphincter defects on ultrasound and 19% have anal incontinence symptoms 1.

Critical Clinical Pitfall to Avoid

Do not assume obstetric history is the primary cause when evaluating postmenopausal women with fecal incontinence. While vaginal delivery contributes to structural damage, community-based studies demonstrate that active bowel disturbances (particularly diarrhea), rectal urgency, and chronic illness burden are far more important independent risk factors than historical obstetric events 1. This distinction is crucial because it directs treatment toward managing current bowel dysfunction rather than focusing solely on structural repair of old obstetric injuries.

Additional Contributing Factors:

  • Disease burden (comorbidity count, diabetes) 1
  • Decreased physical activity 1
  • Anal sphincter trauma (obstetrical injury, prior surgery) 1
  • Neurological disorders (dementia, stroke, spinal cord disease) 1, 4
  • Proinflammatory dietary patterns 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Fecal incontinence in older adults.

Clinics in geriatric medicine, 2007

Research

Proinflammatory Diet Is Associated With Increased Risk of Fecal Incontinence Among Older Women: Prospective Results From the Nurses' Health Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.